The activity of this system is aimed at obtaining pathogens in endemic areas and natural foci, monitoring the biological situation and managing it in their interests, the department noted.
MOSCOW, December 24. /tass/. The American biological risk management system, tested by the United States in Ukraine and Georgia, is used on the African continent. This was stated during a briefing by the deputy head of the radiation, chemical and biological protection forces of the Russian Armed Forces, Major General Alexei Rtishchev.
"Based on the analysis of incoming documents, the structure of the system created by the American Administration for Biological Risk Management in other countries has become clear. It has been successfully tested in Ukraine and Georgia, and is now being actively used on the African continent," said Rtishchev.
He stressed that the activities of this system are aimed at obtaining pathogens in endemic areas and natural foci, monitoring the biological situation and managing it in their interests. One of the tasks is to analyze the epidemic situation along the borders of geopolitical opponents in the proposed areas of deployment of military contingents.
Biocontrol system
Rtishchev noted that the United States is deploying a biological control system on the African continent according to a previously worked-out scenario. "I would like to remind you that the deployment of the American biological control system in Africa is carried out according to an already worked-out scenario. First of all, there is concern about regular outbreaks, such as anthrax and tularemia in one region, foot-and-mouth disease and plague in another," said Rtishchev.
He clarified that, as a rule, this happens during meetings of US ambassadors with representatives of the local Ministry of Health. American diplomats point out that such outbreaks undermine the development of the region's economic potential. The level of training of senior staff and specialists in terms of neutralizing biological threats is questioned, and the need to improve their skills is expressed. Against this background, it is proposed to create a center for disease diagnosis and drug testing within one or two years, which will study dangerous pathogens and the mechanisms of their mutations, develop and test modern vaccines.
According to Rtishchev, at the same time, it is planned to involve local specialists in research projects of the Agency for Reducing the Threat of Weapons of Mass Destruction of the US Department of Defense (DTRA). To this end, it is announced that the United States will prepare a three-month training program for the center's staff. The issue of integrating regional information systems into the American electronic disease surveillance system is also being discussed. Most often, DTRA representatives recommend that partners step up this process, paying special attention to ensuring the smooth operation of appropriate equipment and network communications.
"For these purposes, as a rule, from $5 to $10 million is immediately allocated, with a possible increase in funding to $20 million, taking into account the implementation of the first phase of the project. Government agencies of the United States and private contracting companies, including enterprises of the so-called Big Pharma, are involved in building cooperation with local relevant ministries," said Rtishchev.
